The UK is ahead of Europe and the US and gives the green light to Pfizer’s vaccine
Pfizer’s vaccine will be available in UK next week The UK has become the first…
Biotechnology
Moderna will request authorization for the emergency use of the vaccine in the US and Europe on Monday
Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective Moderna Inc said it will request…
Brussels gives the green light to the agreement with Pfizer to buy 300 million doses
Pfizer’s coronavirus vaccine sparks optimism. The European Commission announced this Wednesday an agreement reached with…
Pfizer will request the authorization of the vaccine from the third week of November
Pfizer’s late-stage coronavirus vaccine trial is near complete. The countdown to the arrival of the…
Singapore startup Breathonix develops 60-second COVID-19 breathalyzer test
Breathonix develops non-invasive breath tests for disease detection. Singapore’s Breathonix has said a clinical trial…
The race for the Covid vaccine reaches the final stretch
45 vaccine candidates in human trials. Governments, companies, health systems and citizens scrutinize with great…
Moderna begins the procedures to market its Covid vaccine in Europe
Moderna prepares for the “commercial launch” of its vaccine. Modern biotechnology begins the procedures to…
Grifols begins clinical trials of its treatment for Covid-19 in patients infected with the virus
Grifols starts the trial to test its immunoglobulin in patients with Covid-19. Grifols has announced…
Foghorn blows its klaxon, gunning for a $100M IPO hot on the heels of its Merck deal
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells…
Sanofi buys Principia Biopharma for 3.11 billion euros
Merger between Sanofi and Principia Biopharma. The French pharmaceutical Sanofi has reached a “definitive agreement”…
Moderna gets positive results in its COVID-19 vaccine
Moderna claims its COVID-19 vaccine produces a “robust” immune response. Scientists around the world will…
FDA spurns CytoDyn’s HIV drug because of missing info
CytoDyn rejected by the FDA. The FDA rejected CytoDyn’s application for its lead program, an…